| Oct 9 |
Strong validation of Evaxion’s AI-Immunology™ platform in multiple clinical trials
|
| Oct 4 |
Evaxion Biotech Charts Future with Innovative Immune Therapies
|
| Oct 3 |
AI from EVAX Improves Trial Results
|
| Oct 3 |
Recent clinical data confirms significantly improved predictive power of Evaxion's AI-Immunology™ platform
|
| Sep 26 |
Evaxion stock jumps on expanded vaccine development pact with MSD
|
| Sep 26 |
Evaxion significantly expands vaccine development collaboration with MSD
|
| Sep 26 |
EVAX Process Continues to Garner Interest and Investment
|
| Sep 20 |
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
|
| Sep 19 |
Evaxion launches improved AI-Immunology™ platform for vaccine antigen prediction
|
| Sep 16 |
Life Sciences Virtual Investor Forum Agenda Announced for September 19th
|
